Catalyst Wire Dossier Catalyst Wire Dossier

IDP-124 Lotion

IDP-124 lotion · Bausch Health Americas, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IDP-124 Lotion, covering 2023-05-08 to 2023-05-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects [Phase 3]

See pricing